Because of the challenges inherent in researching and developing anticancer therapeutics, it is critical that you have the right tools and resources available to you. To facilitate your selection of the most active agent and the most appropriate dose regimens, Charles River offers years of experience in providing high-quality animal models as well as unsurpassed drug expertise in testing a variety of anticancer agents in a broad spectrum of in vitro and in vivo models, including human tumor grafts, syngeneic, orthotopic, angiogenic and genetically engineered. Our models can be augmented with the use of imaging technologies.
Other services we offer to help you with the drug evaluation process include combination chemotherapeutic and radiation therapy, neurotoxicity, cachexia, biomarker assessment, pharmacokinetics, pharmacodynamics, histopathology and immunohistochemistry. We will consult with you to develop detailed study protocols that meet your specific needs.
Oncology Research Products & Services
Experience
- Chemotherapeutics
- Chemopreventive agents
- Blood cell factors
- Immunotherapy
- Targeted therapies
- Supportive care therapies
Related Archived Webinars
Molecular Quarantine for Research Biologics: PCR to Protect Your Research (September 2010)
Current Principles of Preclinical Tumor Models and Endpoints (July 2010)
Effective Use of Translational Imaging for Early Indication of Treatment Response (April 2010)
The Right Model for Your Oncology Research: A Review of the Spontaneous Immunodeficient Rodent Models Used in Oncology Research (February 2010)
In Vitro Assays and Biomarker Analysis to Support Drug Discovery and Preclinical Models of Disease (February 2010)
Our global infrastructure, harmonized approach and commitment to quality allow us to provide unparalleled service in the field of cancer research. For more information, please contact us at askcharlesriver@crl.com.